Scannell Timothy J - 08 Jun 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
By: /s/ Steven Robbins, Attorney in Fact for Timothy J. Scannell
Issuer symbol
NVCR
Transactions as of
08 Jun 2022
Net transactions value
$0
Form type
4
Filing time
10 Jun 2022, 16:10:55 UTC
Previous filing
09 Jun 2022
Next filing
24 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Award $0 +8,700 $0.000000 8,700 08 Jun 2022 Ordinary Shares 8,700 $77.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to buy 8,700 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.